PharmaVOICE Magazine Announces the 2016 PharmaVOICE 100 and Red Jacket Award

TITUSVILLE, NJ--(Marketwired - August 01, 2016) - Established a dozen years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of inspirational and innovative individuals recognized for their positive contributions to the life-sciences industry.

These individuals illustrate what it means to think bigger, do more, and lead with passion and integrity. Based on their profiles, it is no surprise that you, our readers, have identified this year's honorees as some of the most inspiring, motivating, innovative, and outstanding leaders in the life-sciences industry today.

The distinguished honorees are nominated by thousands of PharmaVOICE readers throughout the year and are selected based on substantive accounts describing how they have inspired or motivated their colleagues, peers, and even competitors; have affected positive changes in their own organizations through innovative and game-changing strategies and thinking; as well as giving back to their communities and other philanthropic causes.

The PharmaVOICE 100 honorees represent a broad cross section of the global life-sciences industry, including pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, advertising, digital, marketing, technology, academia, and many other sectors. This diverse group of individuals also represents a wide variety of functional areas ranging from the clinic to the C-suite.

"This must-read issue has become one of the most-anticipated and highly regarded publications of the year, and it is our great pleasure to showcase the 100 men and women who are demonstrating inspired leadership, innovating across the ecosystem, creating transformative change, disrupting the status quo, and building relationships to position the industry in the best way possible to serve the ultimate stakeholders: patients," said Taren Grom, Editor and Co-founder of PharmaVOICE. "We are also pleased to recognize our Red Jacket Award honorees. This hall of fame award honors individuals who have been recognized previously as a PharmaVOICE 100 honoree. They cross a multitude of industry sectors and they have raised the bar in terms of what it means to be an inspired leader for their teams, their companies, their communities, and for the industry at large. They are inspired leaders for today and tomorrow."

The 2016 Red Jacket Award honorees are: Kathy Giusti, Founder, Multiple Myeloma Research Foundation & Consortium; Michelle Keefe, President and CEO, Publicis Touchpoint Solutions; Stuart Peltz, Ph.D., CEO, PTC; Christine Pierre, Founder and President, Society for Clinical Research Sites; and Mike Rea, CEO, IDEA Pharma.

View the 2016 list of the PharmaVOICE 100 at: www.pharmavoice.com. Follow the conversation on Twitter at #2016PV100

About PharmaVOICE:

Published monthly, with the combined July/August PharmaVOICE 100 and November/December Year in Preview issues, PharmaVOICE is expressly written and designed to deliver the views, opinions, and insights of the executives who are shaping the direction of the dynamic and multifaceted life-sciences industry. PharmaVOICE reaches more than 41,000 BPA qualified subscribers and 100,000 users with its digital edition.

PharmaVOICE's unique horizontal editorial approach cuts across industry silos, providing a holistic overview of the life-sciences industry, addressing a range of topics from molecule through market. By engaging compelling personalities from diverse industry sectors, PharmaVOICE provides multiple perspectives on business challenges, trends, and topics. Editorial content sparks dialog, initiates debate, and opens the lines of communication to facilitate and improve business-to-business relationships. PharmaVOICE's multiple-perspective and in-depth original forums, feature articles, topics, and departments are audience-driven. PharmaVOICE provides executives with useful peer-to-peer insights on a broad range of business practices and topics to a wide range of life-science sectors.